Our Pipeline

Together with Danish partner Ranger Biotechnologies A/S, we are focus on developing new medicines for diseases of the liver, the CNS and the eye. There are some current R&D projects and progress, please check the below information:

Retinal Scarring

Preclinical stage

Fibrosis in heart muscle

Preclinical stage

NASH

Discovery stage

Neurodegenerative/neurovascular disease

Discovery stage